TriAgenics
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $3.5M
Investors
- 1
About TriAgenics
TriAgenics, Inc. is a dental technology company focused on innovative solutions to prevent wisdom teeth formation, enhancing patient care through non-invasive procedures. Founded in 2017 in Redmond, US, TriAgenics, Inc. specializes in dental technology aimed at preventing wisdom teeth complications. In September 2025, TriAgenics, Inc. TriAgenics, Inc. specializes in innovative dental technology, specifically focused on the prevention of wisdom teeth formation through their flagship product, the Zero3™ TBA (3rd Molar Tooth Bud Ablation). This minimally invasive procedure is designed to gently warm the developing wisdom tooth buds, effectively blocking their formation within a treatment window of 60 to 90 seconds. The core offering aims to provide a simpler, safer alternative to traditional wisdom tooth extraction, thereby addressing the common dental issue of third molar complications. The company primarily targets dental professionals and oral surgeons, intending to enhance patient care by reducing the need for surgical interventions.TriAgenics, Inc. generates revenue through the commercialization of its Zero3™ TBA procedure within the dental industry, primarily engaging in business-to-business transactions with dental practices and oral surgical centers. The revenue model is based on direct sales of the treatment procedure, which is anticipated to be integrated into existing dental practices' service offerings. Pricing structures are designed to reflect the value of the innovative treatment while considering the operational costs dental professionals encounter when providing care. The company's strategy includes establishing partnerships with dental equipment suppliers to facilitate broader distribution and adoption among end-users, which are primarily dental practitioners serving patients with wisdom teeth issues. With its focus on pioneering dental solutions, TriAgenics aims to build a sustainable revenue stream through the continued development and promotion of its proprietary technology.S. Food and Drug Administration for its Zero3 TBA system.
Who invested in TriAgenics
1 investor across 2 rounds
See all investors in TriAgenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TriAgenics
Who invested in TriAgenics?
TriAgenics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TriAgenics raised?
TriAgenics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TriAgenics last raise money?
TriAgenics's most recent round on record is a Series B, in Sep 2025.
What does TriAgenics do?
TriAgenics is a medical devices & equipment company.
Where is TriAgenics headquartered?
TriAgenics is headquartered in Redmond, US.
Which VCs invest in companies like TriAgenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at TriAgenics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like TriAgenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.